| Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762 A Chaidos, V Caputo, K Gouvedenou, B Liu, I Marigo, MS Chaudhry, ... Blood, The Journal of the American Society of Hematology 123 (5), 697-705, 2014 | 224 | 2014 |
| Deferasirox is a powerful NF-κB inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen … E Messa, S Carturan, C Maffè, M Pautasso, E Bracco, A Roetto, F Messa, ... Haematologica 95 (8), 1308, 2010 | 155 | 2010 |
| Enhanced anti-lymphoma activity of CAR19-iNKT cells underpinned by dual CD19 and CD1d targeting A Rotolo, VS Caputo, M Holubova, N Baxan, O Dubois, MS Chaudhry, ... Cancer Cell 34 (4), 596-610. e11, 2018 | 134 | 2018 |
| The prospects and promise of chimeric antigen receptor immunotherapy in multiple myeloma A Rotolo, V Caputo, A Karadimitris British Journal of Haematology 173 (3), 350-364, 2016 | 29 | 2016 |
| Development of a fully canine anti-canine CTLA4 monoclonal antibody for comparative translational research in dogs with spontaneous tumors NJ Mason, N Chester, A Xiong, A Rotolo, Y Wu, S Yoshimoto, P Glassman, ... MAbs 13 (1), 2004638, 2021 | 23 | 2021 |
| Building upon the success of CART19: chimeric antigen receptor T cells for hematologic malignancies A Rotolo, A Karadimitris, M Ruella Leukemia & lymphoma 59 (9), 2040-2055, 2018 | 19 | 2018 |
| CRISPR-Cas9 knock out of CD5 enhances the anti-tumor activity of chimeric antigen receptor T cells I Chun, KH Kim, YH Chiang, W Xie, YGG Lee, R Pajarillo, A Rotolo, ... Blood 136, 51-52, 2020 | 17 | 2020 |
| Genetic re-direction of canine primary T cells for clinical trial use in pet dogs with spontaneous cancer A Rotolo, MJ Atherton, BT Kasper, KP Haran, NJ Mason STAR protocols 2 (4), 100905, 2021 | 16 | 2021 |
| Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma K Watanabe, AM Gomez, S Kuramitsu, M Siurala, T Da, S Agarwal, ... Blood advances 7 (14), 3416-3430, 2023 | 14 | 2023 |
| Case report: clinical and serological hallmarks of cytokine release syndrome in a canine B cell lymphoma patient treated with autologous CAR-T cells MJ Atherton, A Rotolo, KP Haran, NJ Mason Frontiers in Veterinary Science 9, 824982, 2022 | 12 | 2022 |
| The next questions in chronic myeloid leukaemia and their answers D Marin, A Rotolo, D Milojkovic, J Goldman Current opinion in hematology 20 (2), 163-168, 2013 | 10 | 2013 |
| Emerging drugs for chronic myeloid leukemia D Cilloni, E Messa, A Rotolo, G Saglio Expert Opinion on Emerging Drugs 15 (2), 175-184, 2010 | 8 | 2010 |
| Unedited allogeneic iNKT cells show extended persistence in MHC-mismatched canine recipients A Rotolo, EC Whelan, MJ Atherton, I Kulikovskaya, D Jarocha, JA Fraietta, ... Cell Reports Medicine 4 (10), 2023 | 5 | 2023 |
| Systemic Mastocytosis: An Intriguing Disorder A Rotolo, U Familiari, P Nicoli, D Cilloni, G Saglio, A Guerrasio Hematology - Science and Practice 18, 467-486, 2012 | 5 | 2012 |
| Abstract# 2866: EphA3 is abnormally expressed in chronic myeloprolipherative disorders and could represent a new molecular target F Arruga, F Messa, S Carturan, M Pradotto, C Maffè, M Pautasso, ... Cancer Research 69 (9_Supplement), 2866-2866, 2009 | 4 | 2009 |
| Detection of humoral immune responses against WT1 antigen in patients affected by different hematological malignancies P Nicoli, I Defilippi, S Carturan, A Roetto, F Messa, F Arruga, E Messa, ... Acta Haematologica 120 (1), 47-50, 2008 | 3 | 2008 |
| Disabled gene is involved in CML progression and its expression level at diagnosis can predict major molecular response (MMR) to imatinib therapy F Arruga, F Messa, M Pradotto, R Bernardoni, E Bracco, S Carturan, ... Cancer Research 70 (8_Supplement), 251-251, 2010 | 2 | 2010 |
| Identification of Rab5 as a Gene Involved in Chronic Myeloid Leukemia (CML) Progression. D Cilloni, M Pradotto, F Messa, F Arruga, E Bracco, S Carturan, C Maffè, ... Blood 114 (22), 3470, 2009 | 2 | 2009 |
| Herpetic leg paralysis and abdominal ileus in a patient with idiopathic myelofibrosis P Nicoli, M Bosa, A Rotolo, D Cilloni, G Saglio Internal and emergency medicine 4, 65-66, 2009 | 2 | 2009 |
| Defining the cellular origin of seminoma by transcriptional and epigenetic mapping to the normal human germline K Cheng, Y Seita, EC Whelan, R Yokomizo, YS Hwang, A Rotolo, ... Cell Reports 43 (6), 2024 | 1 | 2024 |
Giuseppe SaglioProfessore di Ematologia, Universita' di Torino在 unito.it 的电子邮件经过验证
